Fig. 3From: The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosisa TGF- β1 sputum concentration and FEV1 slope group, b TGF- β1 sputum concentration and FEV1 group over five yearsBack to article page